| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.23B | +2.7% |
| Cost of Revenue | $2.50B | +1.2% |
| Gross Profit | $3.73B | +3.8% |
| R&D Expense | $414.0M | +4.1% |
| SG&A Expense | $2.17B | +5.4% |
| Operating Income | $1.21B | +6.4% |
| Interest Expense | -$152.8M | -223.7% |
| Pre-tax Income | $969.6M | -2.1% |
| Income Tax | $136.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $813.3M | -56.9% |
| Accounts Receivable | $945.4M | -1.6% |
| Inventory | $544.8M | +1.5% |
| Current Assets | $2.59B | -29.4% |
| Total Assets | $17.02B | +0.6% |
| Current Liabilities | $2.24B | +25.0% |
| Long-term Debt | $3.71B | +1.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.53B | +12.8% |
| Capital Expenditures | $120.4M | +11.7% |
| Investing Cash Flow | -$1.80B | -819.1% |
| Financing Cash Flow | -$792.7M | -2554.2% |
| Free Cash Flow | $1.41B | +12.9% |
| +9.4% |
| Net Income | $832.9M | -3.8% |
| EPS (Basic) | $2.39 | -2.8% |
| EPS (Diluted) | $2.36 | -2.9% |
| Stockholders' Equity |
| $10.19B |
| -1.3% |